| 1 |
35197069 | Combination treatment of docetaxel with caffeic acid phenethyl ester suppresses the survival and the proliferation of docetaxel-resistant prostate cancer cells via induction of apoptosis and metabolism interference. | 2022 Feb 23 |
3 |
| 2 |
34602402 | Study of the radiosensitization of docetaxel in human esophageal squamous carcinoma ECA109 cell line. | 2021 May |
3 |
| 3 |
34914264 | [Effects of silencing HMGB1 combined with docetaxel chemotherapy on the proliferation and apoptosis of prostate cancer cells and its action mechanism]. | 2021 Oct 20 |
1 |
| 4 |
32685011 | TGF-β causes Docetaxel resistance in Prostate Cancer via the induction of Bcl-2 by acetylated KLF5 and Protein Stabilization. | 2020 |
4 |
| 5 |
30880686 | The transcription factor ZEB1 promotes chemoresistance in prostate cancer cell lines. | 2019 Sep-Oct |
2 |
| 6 |
29207126 | Melatonin enhances the apoptotic effects and modulates the changes in gene expression induced by docetaxel in MCF‑7 human breast cancer cells. | 2018 Feb |
1 |
| 7 |
29460131 | Inhibiting autophagy overcomes docetaxel resistance in castration-resistant prostate cancer cells. | 2018 Apr |
2 |
| 8 |
29678549 | Reversal of drug resistance by planetary ball milled (PBM) nanoparticle loaded with resveratrol and docetaxel in prostate cancer. | 2018 Jul 28 |
1 |
| 9 |
30402442 | ABT-737 ameliorates docetaxel resistance in triple negative breast cancer cell line. | 2018 Nov |
2 |
| 10 |
28462831 | Brefeldin A enhances docetaxel-induced growth inhibition and apoptosis in prostate cancer cells in monolayer and 3D cultures. | 2017 Jun 1 |
1 |
| 11 |
28553168 | The Effects and Mechanism of YK-4-279 in Combination with Docetaxel on Prostate Cancer. | 2017 |
2 |
| 12 |
28799743 | Reducing Interstitial Fluid Pressure and Inhibiting Pulmonary Metastasis of Breast Cancer by Gelatin Modified Cationic Lipid Nanoparticles. | 2017 Sep 6 |
1 |
| 13 |
28981599 | DKK4-knockdown enhances chemosensitivity of A549/DTX cells to docetaxel. | 2017 Oct 1 |
1 |
| 14 |
29216925 | Silencing of miR-193a-5p increases the chemosensitivity of prostate cancer cells to docetaxel. | 2017 Dec 8 |
2 |
| 15 |
26189652 | Nitric Oxide Up-Regulates RUNX2 in LNCaP Prostate Tumours: Implications for Tumour Growth In Vitro and In Vivo. | 2016 Feb |
1 |
| 16 |
26511813 | Caveolin-1 Modulates Docetaxel-Induced Cell Death in Breast Cancer Cell Subtypes through Different Mechanisms. | 2016 Apr |
1 |
| 17 |
27082738 | Docetaxel induces Bcl-2- and pro-apoptotic caspase-independent death of human prostate cancer DU145 cells. | 2016 Jun |
3 |
| 18 |
27177833 | Noscapine chemosensitization enhances docetaxel anticancer activity and nanocarrier uptake in triple negative breast cancer. | 2016 Aug 1 |
1 |
| 19 |
27390258 | Docetaxel-Chitosan nanoparticles for breast cancer treatment: cell viability and gene expression study. | 2016 Dec |
4 |
| 20 |
28032735 | Combined Treatment with Stattic and Docetaxel Alters the Bax/Bcl-2 Gene Expression Ratio in Human Prostate Cancer Cells | 2016 Nov 1 |
3 |
| 21 |
25787766 | Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy. | 2015 Mar 18 |
1 |
| 22 |
26099171 | Regulation of BAX/BCL2 gene expression in breast cancer cells by docetaxel-loaded human serum albumin nanoparticles. | 2015 Jul |
2 |
| 23 |
26843836 | Role of microRNAs in the resistance of prostate cancer to docetaxel and paclitaxel. | 2015 |
1 |
| 24 |
24568489 | Mechanisms of hela cell apoptosis induced by abnormal Savda Munziq total phenolics combined with chemotherapeutic agents. | 2014 |
1 |
| 25 |
24939178 | Regulation of SOD2 and β-arrestin1 by interleukin-6 contributes to the increase of IGF-1R expression in docetaxel resistant prostate cancer cells. | 2014 Jul |
1 |
| 26 |
25333266 | Bcl-2 family inhibition sensitizes human prostate cancer cells to docetaxel and promotes unexpected apoptosis under caspase-9 inhibition. | 2014 Nov 30 |
3 |
| 27 |
23566222 | Targeting the Vav3 oncogene enhances docetaxel-induced apoptosis through the inhibition of androgen receptor phosphorylation in LNCaP prostate cancer cells under chronic hypoxia. | 2013 Apr 8 |
2 |
| 28 |
23991130 | MicroRNA-650 was a prognostic factor in human lung adenocarcinoma and confers the docetaxel chemoresistance of lung adenocarcinoma cells via regulating Bcl-2/Bax expression. | 2013 |
1 |
| 29 |
24058878 | ABT-737, a small molecule Bcl-2/Bcl-xL antagonist, increases antimitotic-mediated apoptosis in human prostate cancer cells. | 2013 |
1 |
| 30 |
24337851 | Inhibitory effects of mild hyperthermia plus docetaxel therapy on ER(+/-) breast cancer cells and action mechanisms. | 2013 Dec |
2 |
| 31 |
21399894 | miRNA-34a is associated with docetaxel resistance in human breast cancer cells. | 2012 Jan |
3 |
| 32 |
22490358 | [The effect of cell killing by ABT-737 synergized with docetaxel in human prostate cancer PC-3 cells]. | 2012 Feb 1 |
1 |
| 33 |
22648782 | Toll-like receptor 4 ligation confers chemoresistance to docetaxel on PC-3 human prostate cancer cells. | 2012 Aug |
1 |
| 34 |
22741011 | Silencing Notch-1 induces apoptosis and increases the chemosensitivity of prostate cancer cells to docetaxel through Bcl-2 and Bax. | 2012 Apr 1 |
2 |
| 35 |
22967442 | [Sensitivity to chemotherapeutic drugs of polyploid tumor cells induced by a spindle poison nocodazole]. | 2012 Jun |
3 |
| 36 |
22975379 | Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumor-initiating cells. | 2012 Sep 11 |
1 |
| 37 |
23019417 | Apicidin and docetaxel combination treatment drives CTCFL expression and HMGB1 release acting as potential antitumor immune response inducers in metastatic breast cancer cells. | 2012 Sep |
1 |
| 38 |
21273177 | Randomized phase II trial of concurrent versus sequential bortezomib plus docetaxel in advanced non-small-cell lung cancer: a California cancer consortium trial. | 2011 Jan |
1 |
| 39 |
21380817 | Role of nonsteroidal anti-inflammatory drug-activated gene-1 in docetaxel-induced cell death of human colorectal cancer cells with different p53 status. | 2011 Feb |
3 |
| 40 |
22011009 | Resveratrol enhances the cytotoxic profile of docetaxel and doxorubicin in solid tumour cell lines in vitro. | 2011 Dec |
1 |
| 41 |
19866475 | CCL2 is induced by chemotherapy and protects prostate cancer cells from docetaxel-induced cytotoxicity. | 2010 Mar 1 |
1 |
| 42 |
19938012 | Downmodulation of Bcl-2 sensitizes metastatic LNCaP-LN3 cells to undergo apoptosis via the intrinsic pathway. | 2010 May 1 |
1 |
| 43 |
20416158 | [Docetaxel induces apoptosis and influences the expression of P-gp, BCL-2 and BAX protein in HL-60/ADR cells]. | 2010 Apr |
3 |
| 44 |
20663169 | Tian Xian Liquid (TXL) induces apoptosis in HT-29 colon cancer cell in vitro and inhibits tumor growth in vivo. | 2010 Jul 21 |
1 |
| 45 |
19103299 | Docetaxel/zoledronic acid combination triggers apoptosis synergistically through downregulating antiapoptotic Bcl-2 protein level in hormone-refractory prostate cancer cells. | 2009 Feb |
1 |
| 46 |
19297314 | Docetaxel plus oblimersen sodium (Bcl-2 antisense oligonucleotide): an EORTC multicenter, randomized phase II study in patients with castration-resistant prostate cancer. | 2009 Jul |
1 |
| 47 |
20067883 | Vitamin A family compounds, estradiol, and docetaxel in proliferation, apoptosis and immunocytochemical profile of human ovary endometrioid cancer cell line CRL-11731. | 2009 |
1 |
| 48 |
18190795 | Overexpression of phospholipase D suppresses taxotere-induced cell death in stomach cancer cells. | 2008 May |
1 |
| 49 |
18281755 | [Prediction of response to docetaxel in breast cancer]. | 2008 Feb |
1 |
| 50 |
18357392 | Effects of the proteasome inhibitor bortezomib alone and in combination with chemotherapeutic agents in gastric cancer cell lines. | 2008 Apr |
3 |